Brind.

Halo, a biopharmaceutical company based in San Diego, and Leidos and TransUnion are mentioned as stocks for investment.

14 reports, 2 independent Updated Sep 5
Gone quiet Reached 2 outlets in its first 24 hours
Reports
14
Developments
2
Repetition
86%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Halo, a biopharmaceutical company based in San Diego, and Leidos and TransUnion are mentioned as stocks for investment.

Who's involved

What this event is mainly about
HaloSan DiegoLeidosHalozyme Therapeutics

How it developed

Newest first. Tap a step to see who reported it.
  1. Halo, a San Diego biopharma company, and Leidos/TransUnion are noted as investment stocks.1 source
  2. Halozyme Therapeutics is located in San Diego.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • ZacksBet on These 3 Stocks With Upgraded Broker Ratings for Robust Returns Stock markets have been hitting fresh records lately as investors gain confidence that the Federal Reserve will resume rate cuts
  • ZacksHow to Find Strong Buy Medical Stocks Using the Zacks Rank It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill,
  • ZacksHere's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals f
  • ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors al
  • Insider MonkeyHalozyme Therapeutics (HALO) Fell Despite Reporting Strong Earnings and Improved Guidance Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025
  • Insider MonkeyHere’s Why Halozyme Therapeutics (HALO) Traded Town in Q2 Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” second-quarter 2025 investor letter. A copy of the letter
  • ZacksWhy Halozyme Therapeutics (HALO) is a Top Momentum Stock for the Long-Term It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common
  • ZacksHere's Why Halozyme Therapeutics (HALO) is a Strong Value Stock Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Many investor
  • ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving thos
  • ZacksHere's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Many investo
  • ZacksWhy Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Achie
  • Unknown outlet
  • Unknown outlet
  • Unknown outlet